FlebogammaDIF (GRIFOLS USA, LLC)
Welcome to the PulseAid listing for the Flebogamma drug offered from GRIFOLS USA, LLC. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: | GRIFOLS USA, LLC |
NON-PROPRIETARY NAME: | Immune Globulin (Human) |
SUBSTANCE NAME: | HUMAN IMMUNOGLOBULIN G |
TYPE: | PLASMA DERIVATIVE |
PHARMA CLASS: | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2006-12-21 |
END MARKETING DATE: | 0000-00-00 |
Flebogamma DIF PLASMA DERIVATIVE Details:
Item Description | Flebogamma DIF from GRIFOLS USA, LLC |
LABELER NAME: | GRIFOLS USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.05(g/mL) |
START MARKETING DATE: | 2006-12-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61953-0004_b1e65293-e162-8e24-7108-0c6c2ec14c92 |
PRODUCT NDC: | 61953-0004 |
APPLICATION NUMBER: | BLA125077 |
Other HUMAN IMMUNOGLOBULIN G Pharmaceutical Manufacturers / Labelers: